Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study
Obesity may be associated with an increased overall survival among male patients treated with chemotherapy, whereas not associated with the outcomes in patients treated with immunotherapy or chemoimmunotherapy.
Authors
- Tianqing Chu (ORCID: https://orcid.org/0000-0002-0744-0397)
- Zheng Liang (ORCID: https://orcid.org/0000-0003-4532-4888)
- Jie Qian (ORCID: https://orcid.org/0000-0002-2464-3006)
- Baohui Han (ORCID: https://orcid.org/0000-0003-3534-093X)
- Guangyu Tao (ORCID: https://orcid.org/0000-0002-8823-9969)
- Shuyuan Wang (ORCID: https://orcid.org/0000-0002-6320-9093)
- Lei Cheng (ORCID: https://orcid.org/0000-0003-1311-515X)
- Xueyan Zhang (ORCID: https://orcid.org/0000-0001-7212-3593)
- Hua Zhong (ORCID: https://orcid.org/0000-0003-1869-3493)
- Wei Nie (ORCID: https://orcid.org/0009-0006-0270-2630)
- Jun Lü (ORCID: https://orcid.org/0009-0000-6292-2252)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1186/s12916-024-03688-2
- Citations
- 10
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 2.83
Funders
- Memorial Sloan-Kettering Cancer Center
- Cleveland Clinic
- Case Comprehensive Cancer Center, Case Western Reserve University
- Flatiron Health
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- National Health Commission of the People's Republic of China
- Foundation Medicine